Also being invested in DXB & our 2b trial design announced this week, I had emailed Kathy Harrison CEO of Dimerix, to enquire about Promarker-D being utilised in Dimerix 2b trials as per previous ANN & this is affirmative.
Obviously Kathy could not go into more detail on trial design other than what had been announced (which was in great detail), but was happy for me to share this on HC, knowing I’m invested in both companies...so FYI.
Inspite of drop in SP, (which I view as a good opportunity to average down a little & increase my holding), I do believe PIQ to be a “quiet achiever” at this point in time. GLTAH
PIQ Price at posting:
18.5¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)